Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
BHLHE22	"Beta3, BHLHB5, bHLHe22, CAGL85, TNRC20"	ENSG00000180828	"Basic helix-loop-helix family member e22"	Q8NFJ8	8	64580367-64583628	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 30.7"	"Cell line enriched"	"Detected in some"	23	"THP-1: 40.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 31.9;cerebellum: 34.4;cerebral cortex: 22.4;hippocampal formation: 50.8"	"Group enriched"	"Detected in many"	8	"amygdala: 37.8;cerebellum: 21.5;cerebral cortex: 22.5;hippocampal formation: 63.6"	"HPA064128, HPA064872, HPA067500"	Enhanced									"HPA064128: AB_2685195, HPA064872: AB_2685377, HPA067500: AB_2685855"	"unprognostic (9.17e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.28e-5)"	"unprognostic (7.22e-3)"	"unprognostic (6.47e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.86e-7)"	"unprognostic (3.20e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.86e-1)"	2.9	1.3	30.7	2.9	1.4	0.3	1.7	21.1	15.8	1.7	1.7	1.2	0.3	1.1	0.5	0.4	2.2	0.6	1.1	0.8	27.2	2.1	0.5	1.3	1.4	2.4	1.7	6.5	0.4	1.3	0.5	1.2	0.2	3.4	0.5	1.4	2.5	1.2	5.4	0.5	0.8	1.7	1.1	2.6	2.9	1.1	0.7	0.2	0.0	0.6	0.0	1.3	2.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	1.4	21.1	10.6	27.2	2.1	1.7	6.5	3.4	0.2
CHRNA5		ENSG00000169684	"Cholinergic receptor nicotinic alpha 5 subunit"	P30532	15	78565520-78595269	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"vagina: 33.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054381	Approved		Approved	"Plasma membrane,Focal adhesion sites"				"Focal adhesion sites"	"Plasma membrane"	"HPA054381: "	"unprognostic (2.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.20e-3)"	"unprognostic (6.66e-2)"	"unprognostic (1.29e-3)"	"unprognostic (7.03e-5)"	"prognostic unfavourable (3.64e-5)"	"unprognostic (1.34e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.52e-2)"	"unprognostic (8.97e-2)"	"unprognostic (6.50e-11)"	"unprognostic (4.37e-1)"	"unprognostic (5.39e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.22e-1)"	2.9	3.3	1.7	4.4	1.7	0.6	4.9	1.8	1.7	2.7	6.4	0.4	1.6	7.8	4.7	1.9	4.0	1.1	16.3	2.4	1.7	1.8	0.9	1.8	1.4	2.0	1.9	0.3	1.7	11.8	0.0	0.7	2.1	1.2	3.6	7.1	3.5	1.7	0.7	5.8	1.0	6.8	6.1	1.3	1.9	5.3	9.8	0.6	4.5	1.6	2.9	4.4	5.7	33.9	0.9	1.1	3.4	1.6	1.6	1.4	0.7	6.6	17.1	9.3	5.2	1.1	0.8	3.8	4.9	2.4	5.4	9.9	6.5	31.6	3.9	12.1	1.0	5.9	17.9	7.2	5.6	8.0	21.4	7.3	13.4	6.5	0.6	4.9	10.4	0.3	1.3	1.4	2.0	10.1	7.1	5.2	3.4	14.5	6.2	1.7	7.5	4.7	8.0	10.8	4.0	6.5	15.9	15.8	23.2	11.7	11.4	5.4	25.4	1.2	2.2	7.4	8.9	5.4	15.3	6.0	24.7	4.4	4.5	8.0	6.8	3.0	1.6	2.5	0.8	1.6	0.4	0.3	0.8	0.5	0.9	0.9	1.4	1.4	3.4	1.6	1.3	1.1	0.3	0.7	1.7	1.7	1.8	1.7	1.7	1.8	1.9	0.3	1.2	0.6
DCC	"IGDCC1, NTN1R1"	ENSG00000187323	"DCC netrin 1 receptor"	P43146	18	52340172-53535903	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Developmental protein, Receptor"	"Cancer-related genes, Disease mutation, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 22.0;testis: 16.5"	"Group enriched"	"Detected in some"	4	"AF22: 15.1;U-266/70: 46.8;U-266/84: 22.0"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055376, HPA069552"	Enhanced		Supported	"Golgi apparatus"			25000	"Golgi apparatus"		"HPA055376: , HPA069552: "	"unprognostic (1.96e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.59e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.22e-4)"	"unprognostic (4.14e-2)"	"unprognostic (1.27e-4)"	"unprognostic (7.21e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.69e-3)"	0.5	1.9	6.3	0.8	22.0	0.4	0.6	0.7	10.1	0.8	0.9	1.3	0.0	0.5	0.4	1.0	0.7	0.7	0.5	0.5	18.4	2.0	0.9	0.5	3.8	0.4	1.5	9.9	0.7	1.2	0.6	1.1	0.4	5.3	1.3	0.8	0.0	0.8	3.5	0.4	0.8	0.7	0.5	2.4	0.8	0.8	16.5	6.5	0.7	0.5	0.0	1.1	0.8	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	46.8	22.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	22.0	0.7	10.1	18.4	2.0	1.5	9.9	5.3	6.5
DCX	"DBCN, DC, LISX, SCLH, XLIS"	ENSG00000077279	Doublecortin	O43602	X	111293779-111412429	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Disease mutation, Epilepsy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.1;testis: 6.4"	"Group enriched"	"Detected in some"	8	"SCLC-21H: 33.8;SH-SY5Y: 13.9"	"Cancer enriched"	"Detected in some"	5	"glioma: 5.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	9	"olfactory region: 90.9"	"Region enriched"	"Detected in all"	4	"olfactory region: 130.1"	HPA036121	Enhanced	Supported	Approved	Cytosol				Cytosol		"HPA036121: "	"unprognostic (1.36e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.24e-2)"		"unprognostic (2.33e-3)"	"unprognostic (3.67e-1)"	"unprognostic (4.90e-4)"	"unprognostic (5.02e-3)"	"unprognostic (1.27e-1)"		"unprognostic (1.85e-1)"	0.8	1.1	7.0	0.7	9.2	0.7	3.2	0.7	17.1	0.7	0.6	0.9	0.0	0.7	4.1	3.6	0.6	0.6	0.8	0.7	4.2	5.4	0.5	0.5	0.6	0.7	2.5	6.7	0.6	0.8	0.5	1.0	0.6	3.7	0.5	0.8	0.0	2.2	0.6	0.5	0.7	0.7	0.6	3.0	0.6	1.2	6.4	2.3	0.0	0.6	0.0	0.5	0.6	0.3	0.3	0.4	0.6	0.2	0.7	0.4	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	33.8	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.2	0.1	0.4	0.3	0.3	0.2	0.1	0.3	0.3	0.3	0.6	0.7	0.0	0.4	0.1	0.0	7.0	9.2	0.7	10.8	4.2	5.4	2.5	6.7	3.7	2.3
DNER	"bet, UNQ26"	ENSG00000187957	"Delta/notch like EGF repeat containing"	Q8NFT8	2	229357629-229714558	"Cancer-related genes, Predicted membrane proteins"	"Notch signaling pathway"	"Activator, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 45.6;brain: 85.2;salivary gland: 46.1"	"Group enriched"	"Detected in some"	5	"hTERT-HME1: 39.4;U-138 MG: 66.4;U-87 MG: 39.3"	"Cancer enriched"	"Detected in many"	32	"glioma: 73.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017320	Enhanced						2700000			"HPA017320: AB_1847808"	"unprognostic (4.39e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.73e-2)"	"unprognostic (6.23e-2)"	"prognostic unfavourable (1.05e-4)"	"unprognostic (4.23e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavourable (3.42e-4)"	"unprognostic (2.59e-2)"	"unprognostic (7.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (5.13e-3)"	1.7	45.6	25.4	2.2	26.8	1.3	3.1	19.5	85.2	2.2	2.3	38.4	0.0	1.6	2.1	5.7	1.5	4.1	1.5	6.8	23.9	36.8	9.7	1.3	2.0	1.5	39.8	15.2	1.6	1.9	1.7	9.6	1.5	30.0	2.8	2.2	2.5	46.1	1.6	1.3	2.5	1.9	2.2	26.4	1.3	8.3	2.0	30.4	0.0	1.4	0.0	2.1	1.4	0.2	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.1	0.5	1.0	0.0	0.1	0.1	0.0	0.0	0.3	2.2	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	3.5	0.0	0.3	0.0	0.0	0.7	2.4	1.7	39.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	3.6	0.0	0.4	0.0	3.7	0.0	7.9	0.6	0.2	0.0	0.2	0.0	0.0	0.0	66.4	0.0	2.2	9.9	0.0	0.0	0.0	39.3	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.0	25.4	26.8	19.5	26.6	23.9	36.8	39.8	15.2	30.0	30.4
FGF2	FGFB	ENSG00000138685	"Fibroblast growth factor 2"	P09038	4	122826708-122898236	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 56.5;BJ hTERT+: 33.1;fHDF/TERT166: 61.3;hTERT-HME1: 33.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000125, HPA065502"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Secreted in other tissues"			"Nucleoplasm, Nuclear bodies"		"CAB000125: , HPA065502: "	"unprognostic (1.53e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.33e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (9.85e-4)"	"unprognostic (3.37e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.45e-2)"	"unprognostic (3.45e-3)"	28.1	3.8	19.4	6.9	21.3	0.7	12.1	6.5	15.3	10.2	14.2	10.3	1.9	2.6	17.9	6.3	6.4	10.1	9.4	5.6	17.1	11.0	5.5	2.9	8.3	2.5	9.9	10.7	16.8	2.4	10.1	4.0	8.1	18.6	10.3	5.6	7.5	4.6	11.9	2.0	2.3	4.1	16.2	17.3	1.9	7.6	3.0	12.3	0.0	3.1	3.8	2.7	7.5	14.5	0.8	0.8	0.5	0.5	0.3	1.0	0.0	1.2	3.1	1.7	6.8	4.3	7.2	0.0	56.5	33.1	23.7	13.8	0.0	0.1	0.0	6.6	61.3	0.2	1.8	0.1	23.9	4.4	0.8	0.0	6.4	0.0	12.8	0.3	0.0	3.9	0.3	23.4	33.8	2.6	1.7	1.9	6.1	0.0	0.0	0.0	5.1	1.3	0.0	0.9	0.0	7.5	0.0	1.0	0.9	10.9	0.0	0.4	0.0	0.1	2.3	19.6	3.8	7.2	4.8	3.3	3.6	0.0	5.6	0.0	2.0	0.5	0.5	0.4	0.3	0.4	0.2	0.4	0.5	0.4	0.2	0.8	0.7	1.0	0.4	0.3	0.4	0.8	0.7	0.0	19.4	21.3	6.5	15.3	17.1	11.0	9.9	10.7	18.6	12.3
GRIK4	"GluK4, GRIK, KA1"	ENSG00000149403	"Glutamate ionotropic receptor kainate type subunit 4"	Q16099	11	120511700-120988904	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 19.3;ovary: 8.5"	"Group enriched"	"Detected in some"	4	"HDLM-2: 6.2;HEL: 19.2;T-47d: 5.0"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA074453	Enhanced									"HPA074453: "	"unprognostic (9.63e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.64e-4)"	"unprognostic (1.48e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.84e-11)"	"unprognostic (1.35e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.58e-2)"	1.0	5.4	11.3	1.0	9.0	0.8	1.3	3.9	19.3	1.2	1.1	9.4	0.0	1.2	1.1	0.9	1.2	1.7	1.1	1.6	13.9	7.2	1.0	0.8	3.1	1.0	8.7	11.0	8.5	0.8	0.8	2.6	1.5	12.3	1.5	1.1	0.0	1.1	1.0	1.0	1.3	1.2	1.0	6.3	1.4	0.9	2.0	8.2	0.0	6.3	0.0	1.0	1.2	0.4	0.0	0.0	0.0	0.0	0.7	0.5	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	6.2	0.6	19.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	5.0	0.0	0.2	0.0	0.2	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	11.3	9.0	3.9	14.0	13.9	7.2	8.7	11.0	12.3	8.2
GRIN1	"GluN1, NMDAR1"	ENSG00000176884	"Glutamate ionotropic receptor NMDA type subunit 1"	Q05586	9	137138390-137168762	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	38	"brain: 97.5"	"Cell line enhanced"	"Detected in some"		"REH: 3.0;RPMI-8226: 4.3;SCLC-21H: 9.8;SH-SY5Y: 6.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067773	Enhanced									"HPA067773: "	"unprognostic (3.58e-2)"	"unprognostic (4.51e-1)"	"unprognostic (2.68e-2)"	"unprognostic (5.48e-4)"	"unprognostic (5.20e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.21e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.72e-2)"	1.7	2.0	23.6	2.0	47.5	1.7	1.8	28.1	97.5	1.8	2.0	3.2	0.0	2.2	1.7	1.8	1.7	1.7	1.7	1.7	29.1	26.4	1.8	1.7	1.8	1.8	15.4	37.9	1.7	1.8	1.8	0.0	1.7	22.0	2.2	1.8	0.7	2.5	1.8	1.7	1.8	2.2	1.8	4.7	1.8	1.8	1.9	6.3	0.0	1.7	0.0	1.8	1.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.4	1.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	1.5	0.1	0.0	0.2	0.2	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.9	0.0	0.0	0.1	0.0	3.0	0.0	4.3	0.0	0.0	9.8	6.8	0.1	0.5	0.0	2.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	23.6	47.5	28.1	87.9	29.1	26.4	15.4	37.9	22.0	6.3
KCNG2	"KCNF2, Kv6.2"	ENSG00000178342	"Potassium voltage-gated channel modifier subfamily G member 2"	Q9UJ96	18	79863668-79900184	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 5.3"	"Cell line enhanced"	"Detected in some"		"NB-4: 3.5;U-2 OS: 1.1;U-937: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"hippocampal formation: 31.7"	HPA048628	Enhanced									"HPA048628: "	"unprognostic (1.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.39e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.78e-1)"	"unprognostic (3.61e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.18e-5)"	"unprognostic (1.05e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.63e-2)"	0.2	0.1	1.5	0.8	2.2	0.6	0.0	0.1	2.4	0.0	0.3			1.1	0.3	0.0	0.1	0.0	0.0	0.0	5.3	1.0	0.9	0.1	0.2	0.4	0.0		0.2	0.0	0.0	0.1	0.6		0.0	0.0		0.3	0.0	0.0	0.1	1.1	0.0	0.2	0.3	0.3	1.2			0.0		0.0	0.5	0.0	0.6	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.5	0.0	0.7	0.3	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.7	0.1	0.1	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0										
NEFL	"CMT1F, CMT2E, NF68, NFL, PPP1R110"	ENSG00000277586	"Neurofilament light"	P07196	8	24950955-24957110	"Disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 95.1"	"Group enriched"	"Detected in some"	5	"HEK 293: 112.2;PC-3: 30.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 24.0"					"Cell type enriched"	"Detected in some"	5	"memory CD4 T-cell: 13.7"	"Lineage enriched"	"Detected in single"	138	"T-cells: 13.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014850, HPA015021"	Enhanced	Supported	Approved	"Nuclear speckles,Intermediate filaments"				"Nuclear speckles"	"Intermediate filaments"	"HPA014850: AB_1854397, HPA015021: "	"unprognostic (7.63e-2)"	"unprognostic (1.36e-2)"	"unprognostic (9.53e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (4.91e-4)"	"unprognostic (5.76e-3)"	"unprognostic (7.88e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.17e-3)"	0.7	12.0	10.3	1.4	20.1	0.6	0.6	2.3	92.1	1.8	1.8	3.0	0.0	1.0	0.7	0.8	3.8	0.7	0.6	0.6	14.1		3.5	0.6	0.6	0.7	0.0	23.8	0.7	0.7	0.6	0.0	0.6	95.1	1.6	1.5	5.0	0.6	9.5	0.6	0.7	1.7	1.2	18.0	0.7	1.1	1.6	2.1	0.0	1.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	13.7	2.1	0.0	0.1	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.1	0.0	0.0	112.2	0.0	0.0	0.0	4.9	0.0	0.1	1.8	0.4	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.8	30.1	0.0	0.0	0.0	6.9	1.0	6.2	6.4	2.6	0.0	0.4	0.0	0.0	0.0	0.6	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.7	1.5	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.2	2.1										
NPTX1		ENSG00000171246	"Neuronal pentraxin 1"	Q15818	17	80467148-80477843	"Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 68.9"	"Cell line enhanced"	"Detected in some"		"HAP1: 12.1;HeLa: 9.5;SiHa: 15.4;U-138 MG: 33.0;WM-115: 45.3"	"Cancer enhanced"	"Detected in many"		"glioma: 4.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 74.8;cerebellum: 228.3;cerebral cortex: 119.6;hippocampal formation: 173.6"	HPA077062	Enhanced				"Secreted in brain"		1000000			"HPA077062: "	"unprognostic (2.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.95e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.81e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.05e-6)"	"unprognostic (1.41e-4)"	"unprognostic (1.35e-1)"	"unprognostic (8.86e-6)"	"unprognostic (2.71e-3)"	1.0	3.4	28.8	1.4	14.7	0.8	1.1	68.9	62.5	0.8	9.1	0.2	0.0	1.3	1.3	2.5	1.4	1.4	1.7	0.7	15.5	3.0	0.8	0.7	1.0	1.4	1.0	18.2	0.7	0.7	0.7	0.8	1.6	4.6	1.3	2.5	0.6	0.7	2.9	1.0	3.2	1.5	1.4	1.9	2.3	1.5	1.3	0.0	0.9	0.7	0.0	0.7	0.9	0.2	0.0	0.0	0.0	0.0	1.5	0.3	0.1	0.0	0.7	0.2	0.0	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	12.1	0.0	0.0	0.0	7.5	0.0	9.5	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.5	0.0	0.0	3.1	0.0	0.0	8.2	0.0	15.4	0.0	0.0	0.0	0.2	0.1	33.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	45.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	28.8	14.7	68.9	29.9	15.5	3.0	1.0	18.2	4.6	0.0
PDE1B	PDES1B	ENSG00000123360	"Phosphodiesterase 1B"	Q01064	12	54549350-54579239	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 52.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 11.3;HL-60: 6.3;HMC-1: 12.1;NB-4: 8.0;THP-1: 7.7;U-937: 6.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 52.6"	"Cell type enriched"	"Detected in single"	4	"naive CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.6"	"Region enriched"	"Detected in all"	6	"basal ganglia: 895.2"	"Region enriched"	"Detected in all"	7	"basal ganglia: 253.8"	HPA018492	Enhanced									"HPA018492: AB_1855119"	"unprognostic (2.90e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.67e-4)"	"unprognostic (5.63e-3)"	"unprognostic (7.02e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (4.77e-6)"	"unprognostic (6.64e-4)"	"unprognostic (2.14e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.83e-2)"	12.3	1.4	9.9	4.6	52.6	5.6	2.7	3.1	19.4	2.6	3.7	1.4	0.0	1.2	3.9	2.5	1.7	2.4	2.9	1.9	3.7	3.8	1.3	1.6	2.9	1.6	3.0	9.3	12.5	0.6	11.0	0.5	0.5	5.8	1.0	1.7	0.5	1.3	2.1	0.7	1.0	2.6	4.9	1.2	4.8	2.5	1.1	7.7	0.0	2.7	0.0	1.1	2.8	1.1	0.2	0.3	0.1	0.3	0.1	1.6	0.4	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.0	0.1	0.0	0.0	1.8	0.0	0.0	11.3	0.3	4.6	0.0	0.0	0.0	6.3	12.1	0.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.7	8.0	3.3	0.0	2.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	7.7	0.0	0.0	0.2	0.0	0.0	0.0	0.1	2.4	0.0	6.4	1.2	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.2	1.6	0.0	0.1	0.1	0.0	0.0	0.0	0.4	9.9	52.6	3.1	19.4	3.7	3.8	3.0	9.3	5.8	7.7
PRKCE		ENSG00000171132	"Protein kinase C epsilon"	Q02156	2	45651345-46187990	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, Cell division, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 36.5"	"Cell line enhanced"	"Detected in many"		"REH: 19.1;TIME: 19.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 5.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001948, HPA044496, HPA054252"	Enhanced	Supported	Approved	Vesicles				Vesicles		"CAB001948: , HPA044496: , HPA054252: "	"unprognostic (1.10e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavourable (2.42e-4)"	"unprognostic (9.61e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.51e-1)"	"prognostic favourable (9.62e-4)"	"unprognostic (3.05e-1)"	"unprognostic (6.72e-2)"	"unprognostic (7.49e-3)"	"unprognostic (9.99e-2)"	"prognostic favourable (2.63e-7)"	"unprognostic (1.21e-1)"	"unprognostic (7.11e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.23e-2)"	5.5	7.4	15.3	7.2	14.2	9.3	8.1	28.8	36.5	6.6	5.5	3.8	5.9	3.6	5.6	4.6	4.7	7.6	4.7	7.7	22.5	10.0	12.8	15.5	17.5	6.9	6.0	15.0	4.1	4.2	16.3	6.0	10.4	9.1	3.6	4.7	3.7	3.6	8.6	7.2	3.0	3.7	6.2	4.4	4.9	4.4	7.2	3.7	1.5	6.5	1.2	5.4	5.0	6.5	5.5	2.2	1.7	1.4	0.9	1.3	0.6	5.3	2.0	2.8	2.8	4.3	5.1	2.3	3.8	6.8	3.2	3.4	0.5	5.3	8.1	3.6	3.9	1.3	1.8	2.0	4.5	4.8	3.4	0.0	1.4	1.1	4.9	0.6	2.9	4.5	2.2	4.7	3.4	11.6	1.1	1.9	3.6	2.7	2.6	0.3	1.0	1.0	19.1	13.5	8.6	2.9	3.7	2.0	4.3	1.7	5.7	12.3	4.6	1.9	19.2	6.2	6.5	4.5	3.7	0.0	0.0	6.8	5.1	4.5	6.2	0.0	1.2	1.7	1.0	0.4	1.1	3.6	0.7	0.7	2.2	5.5	1.3	0.4	0.4	0.9	1.4	0.9	0.0	0.6	15.3	14.2	28.8	33.2	22.5	10.0	6.0	15.0	9.1	3.7
PTPRN	"IA-2, ICA512"	ENSG00000054356	"Protein tyrosine phosphatase, receptor type N"	Q16849	2	219289623-219309648	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Receptor	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 89.6;pancreas: 28.9;pituitary gland: 43.4"	"Group enriched"	"Detected in some"	8	"U-2 OS: 19.8;U-87 MG: 73.7"	"Group enriched"	"Detected in some"	12	"glioma: 5.3;pancreatic cancer: 18.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007152, HPA007179"	Enhanced		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA007152: , HPA007179: AB_1079714"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-4)"	"unprognostic (2.91e-3)"	"unprognostic (5.83e-3)"	"prognostic unfavourable (1.45e-7)"	"unprognostic (3.64e-2)"	"unprognostic (1.24e-4)"	"unprognostic (1.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.20e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.28e-10)"	"unprognostic (1.43e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.61e-2)"	1.7	22.3	19.3	4.7	35.7	1.7	1.3	17.3	89.6	1.2	2.4	2.5	0.0	2.5	1.5	1.2	1.5	1.3	1.5	1.4	21.6	40.1	1.5	1.2	1.4	1.3	14.4	19.8	1.3	28.9	1.2	43.4	1.4	22.0	1.4	1.9	3.1	1.2	1.3	1.2	2.0	2.5	2.4	3.5	1.3	6.0	1.4	2.1	0.0	1.5	0.0	1.2	2.7	0.0	0.1	0.3	0.2	0.0	0.0	0.6	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.3	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.1	2.5	0.0	6.1	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	4.8	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.2	73.7	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.6	3.7	19.3	35.7	17.3	54.0	21.6	40.1	14.4	19.8	22.0	2.1
PTPRZ1	"phosphacan, PTP18, PTPRZ, PTPZ, RPTPB"	ENSG00000106278	"Protein tyrosine phosphatase, receptor type Z1"	P23471	7	121873089-122062036	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 118.1"	"Group enriched"	"Detected in some"	9	"AF22: 92.1;NTERA-2: 25.6;WM-115: 40.3"	"Cancer enriched"	"Detected in many"	14	"glioma: 175.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015103	Enhanced		Approved	Vesicles,Cytosol	"Secreted in brain"		950000	Cytosol	Vesicles	"HPA015103: AB_1855946"	"unprognostic (8.49e-4)"	"unprognostic (3.96e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.17e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.72e-6)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.77e-2)"	"prognostic unfavourable (9.36e-4)"	2.0	2.5	33.1	2.3	44.1	1.5	4.0	15.4	118.1	2.4	2.2	19.3	0.0	1.9	1.6	2.0	7.0	1.7	1.9	2.0	39.6	15.9	1.6	1.6	2.1	1.5	18.6	17.8	2.0	3.3	1.5	1.6	1.6	67.6	2.1	2.3	0.8	2.4	2.0	1.5	19.3	1.9	2.4	76.6	2.1	9.8	1.7	23.6	0.0	1.5	1.8	3.0	2.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	5.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	1.1	0.0	0.1	0.0	40.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	44.1	15.4	39.6	39.6	15.9	18.6	17.8	67.6	23.6
RTP5	"C2orf85, CXXC11, FLJ33590, Z3CXXC5"	ENSG00000188011	"Receptor transporter protein 5 (putative)"	Q14D33	2	241869600-241873823	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	18	"brain: 44.8"	"Group enriched"	"Detected in some"	29	"MOLT-4: 3.6;SCLC-21H: 7.2"	"Cancer enriched"	"Detected in single"	10	"glioma: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA050902	Enhanced									"HPA050902: "	"unprognostic (3.26e-2)"	"unprognostic (5.38e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.40e-4)"	"unprognostic (8.68e-3)"	"unprognostic (2.04e-1)"	"unprognostic (6.34e-4)"	"unprognostic (3.30e-1)"	"unprognostic (9.01e-3)"	"unprognostic (3.91e-1)"	"unprognostic (9.08e-8)"	"unprognostic (1.81e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.72e-2)"	0.8	0.8	27.9	1.1	44.8	1.9	0.7	0.2	13.5	0.7	0.7	2.1	0.0	0.9	0.7	0.7	0.7	0.7	0.8	0.8	32.9	24.9	0.7	0.7	0.8	2.4	3.1	4.8	0.7	0.9	0.7	0.0	0.7	7.3	0.7	0.7	0.0	0.9	0.7	0.7	0.7	0.7	0.7	2.1	1.1	0.8	0.7	1.5	0.0	0.7	0.0	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	44.8	0.2	12.7	32.9	24.9	3.1	4.8	7.3	1.5
RUNDC3A	"RAP2IP, RPIP8"	ENSG00000108309	"RUN domain containing 3A"	Q59EK9	17	44308413-44318671	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 92.6"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 34.1;SH-SY5Y: 21.8"	"Cancer enhanced"	"Detected in many"		"glioma: 8.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023548, HPA070733"	Enhanced	Supported	Approved	Vesicles				Vesicles		"HPA023548: AB_1856069, HPA070733: AB_2732162"	"unprognostic (3.66e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.58e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.87e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.87e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.17e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.84e-1)"	1.4	12.9	40.5	1.6	28.5	2.8	1.5	33.0	92.6	1.3	1.8	4.8	0.0	2.2	1.6	1.5	1.5	1.5	1.6	1.8	40.9	20.6	1.7	1.3	1.5	1.4	22.0	23.2	1.7	4.3	2.4	16.1	2.5	15.6	1.5	1.8	1.6	1.4	1.6	1.3	4.1	2.2	1.8	8.0	1.5	3.3	5.2	4.4	0.0	2.4	0.0	1.4	1.5	0.0	0.3	0.1	0.0	0.2	0.1	1.3	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.2	0.2	0.0	0.0	0.5	0.1	0.0	34.1	21.8	0.2	0.0	0.2	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.3	1.3	0.3	0.1	0.1	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	40.5	28.5	33.0	49.2	40.9	20.6	22.0	23.2	15.6	4.4
SYNGAP1	"KIAA1938, RASA5, SYNGAP"	ENSG00000197283	"Synaptic Ras GTPase activating protein 1"	Q96PV0	6	33419661-33457541	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"	"Autism, Autism spectrum disorder, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.9"	"Cell line enhanced"	"Detected in many"		"AF22: 20.7;HMC-1: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.9"	"Group enriched"	"Detected in many"	6	"B-cells: 1.5;T-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038373	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA038373: AB_10670779"	"unprognostic (3.72e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.35e-2)"	"prognostic favourable (2.80e-4)"	"unprognostic (3.66e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.81e-2)"	"prognostic unfavourable (1.34e-6)"	"unprognostic (9.48e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.47e-2)"	4.5	5.0	29.7	11.9	28.6	6.2	4.3	27.2	33.7	7.8	5.9	5.5	2.4	6.0	13.0	5.3	4.2	11.9	6.1	4.4	37.9	7.6	4.0	2.2	5.9	10.3	4.1	38.9	12.8	3.5	10.0	26.1	6.2	7.9	6.3	4.7	3.2	3.7	7.1	2.3	6.2	5.7	11.1	8.7	9.7	4.9	8.7	9.3	8.9	5.6	0.2	7.0	6.9	6.4	1.5	0.1	0.1	0.2	0.0	1.9	0.0	2.0	0.9	20.7	7.7	4.3	4.5	2.6	5.0	3.2	2.8	2.2	8.6	0.8	5.8	1.3	2.4	3.0	2.6	2.9	2.0	3.3	1.6	14.5	2.3	0.5	2.9	2.2	17.0	3.1	0.9	5.2	2.5	2.0	4.5	2.7	2.0	4.3	3.5	3.4	10.4	2.2	13.6	0.5	2.4	2.1	1.5	5.0	4.0	1.9	3.6	1.6	7.9	2.1	0.6	5.9	5.8	2.3	0.9	3.2	1.1	4.3	3.4	2.6	1.4	0.0	0.2	0.1	0.3	0.0	0.8	0.1	1.9	0.9	0.0	1.5	0.9	0.2	0.1	0.0	0.1	0.1	0.1	0.0	29.7	28.6	27.2	33.7	37.9	7.6	4.1	38.9	7.9	9.3
TMEM255A	"FAM70A, FLJ20716"	ENSG00000125355	"Transmembrane protein 255A"	Q5JRV8	X	120258650-120311556	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 30.4;ovary: 29.6"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 16.9;RPMI-8226: 10.8;SK-MEL-30: 17.7;U-2 OS: 7.6;U-87 MG: 19.3"	"Group enriched"	"Detected in many"	10	"glioma: 21.3;melanoma: 8.0;renal cancer: 7.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"gdT-cell: 5.9;MAIT T-cell: 3.3;memory CD8 T-cell: 2.2;naive CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	10	"T-cells: 5.9"	"Low region specificity"	"Detected in all"							HPA048470	Approved		Uncertain	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA048470: AB_2680406"	"unprognostic (3.41e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.55e-4)"	"unprognostic (7.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.55e-4)"	3.9	5.5	6.8	3.4	14.4	1.5	5.4	6.8	7.8	11.2	3.5	12.4	1.7	1.9	3.2	2.9	4.4	6.3	2.1	2.4	5.3	25.4	2.4	1.5	4.8	5.0	30.4	4.4	29.6	1.1	0.6	6.6	0.8	18.4	3.8	3.9	7.1	1.3	3.3	2.4	4.0	2.8	2.0	13.0	2.8	2.1	0.9	7.8	6.4	0.9	1.8	5.7	1.6	8.0	0.5	0.3	0.0	0.6	0.0	5.9	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.3	0.1	0.0	0.1	0.2	0.0	0.0	1.1	0.4	0.5	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	16.9	0.3	0.0	0.0	0.0	5.9	0.0	0.0	0.0	10.8	0.0	0.0	3.4	0.1	0.3	0.0	17.7	0.0	0.2	0.0	0.0	7.6	0.0	2.8	0.0	3.2	2.4	19.3	0.0	0.0	0.0	0.6	0.0	5.9	0.2	3.3	0.5	0.4	2.2	0.3	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.9	6.8	14.4	6.8	3.9	5.3	25.4	30.4	4.4	18.4	7.8
YJEFN3	"FLJ44968, hYjeF_N3-19p13.11"	ENSG00000250067	"YjeF N-terminal domain containing 3"	A6XGL0	19	19528861-19537581	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 47.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.2;HEK 293: 13.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA060789	Enhanced		Approved	Mitochondria				Mitochondria		"HPA060789: "	"unprognostic (2.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (5.99e-6)"	"unprognostic (1.65e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.37e-4)"	"unprognostic (2.38e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (7.25e-4)"	"unprognostic (2.11e-2)"	"prognostic unfavourable (1.30e-7)"	"unprognostic (1.17e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.49e-3)"	1.2	0.9	24.2	1.4	47.8	0.8	1.0	0.8	26.5	1.1	1.3	1.1	0.0	1.0	1.3	6.6	1.0	1.6	0.9	0.8	29.5	8.3	1.0	0.8	1.4	1.4	7.7	10.2	1.1	1.0	1.7	0.8	1.3	3.6	2.0	1.6	4.1	0.9	1.5	1.6	3.0	1.6	1.2	1.0	1.1	1.4	7.1	5.1	0.0	1.7	0.0	1.3	1.5	0.0	0.5	0.5	0.3	1.1	0.0	2.2	0.3	0.2	0.8	1.9	0.8	0.3	0.5	11.2	0.5	0.1	0.4	0.7	0.9	0.6	0.4	1.4	0.1	1.1	0.3	0.2	0.0	0.1	13.1	0.0	1.5	0.0	0.1	0.3	0.5	0.1	0.5	0.2	0.4	0.0	0.9	0.6	0.0	0.9	0.0	0.1	3.5	2.6	2.1	0.4	0.4	0.0	0.1	0.3	3.1	0.2	0.0	0.2	1.2	1.6	0.7	0.3	0.7	3.4	0.7	3.2	2.1	0.6	0.2	1.7	0.4	0.0	0.7	0.0	0.7	1.1	0.8	0.3	1.2	0.6	0.5	0.5	0.7	1.1	0.3	0.0	0.7	0.0	2.2	0.3	24.2	47.8	0.8	26.5	29.5	8.3	7.7	10.2	3.6	5.1